INHIBIKASE THERAPEUTICS INC
IKT · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $1.87
- Today’s Low
- $1.73
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.95
- Previous Close
- $1.84
- Volume
- 741.43K
- Market Cap
- $257.44M
- P/E Ratio
- --
- EPS
- $-0.49
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1000 N. WEST STREET, WILMINGTON, DE, UNITED STATES, 19801
- Country
- US
- Listing Date
- 2020-12-23
- Fiscal Year End
- December
- Shares Outstanding
- 157.03M
- CIK
- 0001750149
- Website
- www.inhibikase.com
Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapies for Parkinson's disease (PD) and related disorders that arise inside and outside the brain. The company is headquartered in Atlanta, Georgia.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$21.05M
2026-03-31
$18.21M
2025-12-31
$13.77M
2025-09-30
$12.76M
Net Income
2026-06-30
-$19.59M
2026-03-31
-$16.38M
2025-12-31
-$12.73M
2025-09-30
-$11.93M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.11
2026-03-31
$-0.09
2025-12-31
$-0.09
2025-09-30
$-0.13
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$19.59M
2026-03-31
-$16.38M
2025-12-31
-$13.13M
2025-09-30
-$13.23M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $21.05M | $18.21M | $13.77M | $12.76M |
| Net Income | -$19.59M | -$16.38M | -$12.73M | -$11.93M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.11 | $-0.09 | $-0.09 | $-0.13 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$19.59M | -$16.38M | -$13.13M | -$13.23M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.